SanMelix Laboratories, Inc. (“SanMelix”) was formed to commercially develop bioactive wound dressings and compositions that have shown remarkable efficacy in the treatment of a variety of wound and dermal afflictions.
Dr. Sabacinski co-invented our patented BEECure™ M product which demonstrated superior clinical outcomes. Our products have higher standardization and broader spectrum anti-microbial activity allowing them to be used by physicians in the fight against anti-microbial resistance pathogens.
The Company was founded by Dr. Kenneth A. Sabacinski, Diana Sabacinski, CPA, and John Kaufman in 2016. Dr. Sabacinski has thirty years of clinical experience in the medical and surgical treatment of limb-threatening and chronic wounds. Diana Sabacinski has significant business management and financial experience in the healthcare and manufacturing industries. Mr. John Kaufman is an engineer with 40 years of management experience working with the Government, business start-ups, and large scale manufacturing. The combined experience of management provides significant clinical proficiency, engineering, financial management, and Government contracting experience, which will greatly contribute to the success of SanMelix.
During his years of clinical practice, Dr. Sabacinski has successfully treated acute and chronic wounds with various topical broad-spectrum organic antibiotic solutions. In addition to his surgical treatment of wounds, he preferred a natural or organic product which would not have adverse side effects in patients, especially those with poor circulation and diabetes. Early in his career, he experimented with povidone-iodine and sugar for wound healing. More recently, Dr. Sabacinski has researched and developed bioactive wound dressings using buckwheat honey fortified with antibacterial compounds.
The reason Dr. Sabacinski developed the BEECure™ dressings was to prevent the undesirable and dangerous side effects and adverse drug interactions that are well known for the predominantly synthetic pharmaceuticals that have been widely administered over the past several decades. With the resistance problems resulting from the overuse of current day antibiotics (the AMR crisis), many research groups have gone back to study, in greater detail, the medicinal properties, and mechanisms of action of many natural and organic compounds, such as honey.
As a result of his clinical outcomes, Dr. Sabacinski co-invented SanMelix’s bioactive wound dressings, which involve novel medicinal activities associated with buckwheat honey combined with other protective additives. The Company’s BEECure™ dressings prevent life threating bacteria from penetrating the dressing. Based on Dr. Sabacinski’s limited initial case studies (performed on an emergency off-protocol basis) results demonstrated enhanced and hastened healing of the chronic wounds.
Mrs. Sabacinski is a Certified Public Accountant (CPA) and Certified Fraud Examiner (CFE) with more than 25 years of public accounting and C-level management experience in the service, manufacturing, distribution, government contracting, and health care industries. She began her career at the international accounting firms of Deloitte, Haskins & Sells and Coopers & Lybrand.
After obtaining her CPA license, she worked as a Vice President of Finance of a public manufacturing company. Subsequently from 1989 to 2001, she co-founded, co-owned, and operated a multi-location (7) computer training organization, ExecuTrain of Florida (ETF). ETF was listed on the INC 500 Fastest Growing Companies in 1992, and ETF received numerous awards for revenue, growth, profitability, and quality of services.
Upon sale of ETF, Mrs. Sabacinski worked as a consultant and Director of Advisory Services for start-ups focused in the healthcare and manufacturing industries. Diana’s SanMelix responsibilities include major corporate decisions, managing the overall operations and resources of the company, regulatory compliance, and acting as the main point of communications between the board of directors and investors.
Marie Williams is a profit-driven and process-oriented manager with 15+ years’ experience in education and healthcare. Marie has been helping companies reach their goals by opening the lines of communication between employees, clients, customers, and businesses to get projects done. In her previous position at AORN (recognized as a “Top Healthcare Company” by Becker’s Hospital Review for multiple years in a row) she was responsible for promoting their evidence-based education and practices to various healthcare organizations throughout the United States. As a Director of Admissions, Marie also has experience building, educating, and mentoring top-notch sales teams.
As the Operations Manager, Marie is directly responsible for ensuring the day-to-day processes at SanMelix run efficiently, while performing customer service activities, accounts receivable, billing and payroll duties. Born, raised and educated in Ireland, Marie believes in simplicity in life and work. Focus on what is important, take care of your family, and focus on the customer.
Dr. Sabacinski is board certified and has over 30 years’ clinical experience in Foot & Ankle medicine, surgery, and limb salvage. Dr. Sabacinski performed his internship, residency and fellowship training at the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. During his residency at the Beth Israel Deaconess Medical Center and the Joslin Diabetes Center, he was specifically trained in the treatment of acute and chronic diabetic foot ulcers.
His private practice continues to focus on wound care treatment. Dr. Sabacinski will be responsible for coordination of clinical studies and research and development. In addition, he will be responsible for presenting the products to other physicians at medical trade shows and training other physicians in the use of the products. Dr. Sabacinski is the inventor of multiple advanced wound care patents, including the SanMelix’s BEECure™ wound care dressings.